Venture Capital

Updated:

Advent Venture Partners

Advent Venture Partners, founded 1981, is a London-based venture capital firm backing European enterprise software and life sciences companies.

Advent Venture Partners

Advent Venture Partners is a European venture capital firm founded in 1981. The firm manages over Euro 500m in fund commitments, focusing on venture and growth investments in Life Sciences and Technology. Advent Venture Partners has made 81 investments and 32 portfolio exits, including its latest exit of PaxMedica on August 26, 2022.

General information

Firm type

Venture Capital

Year founded

1981

AUM

Undisclosed

Location

Region

Europe

Country

United Kingdom

City

London

Corporate office

London, United Kingdom

Principals

Peter Baines

General Partner

Mike Chalfen

General Partner

James Mawson

General Partner

Sector focus

Enterprise SoftwareDigital HealthAI/MLFinTech

Frequently asked questions

Who runs investment decisions at Advent Venture Partners?

The firm is led by a partnership that has included Peter Baines, Mike Chalfen, and James Mawson over multiple fund cycles. Investment decisions are made collectively by the partnership, a structure typical of European venture firms of Advent's vintage. The partnership has remained relatively stable, with Chalfen and Mawson having been with the firm for over two decades (per the firm's official communications).

Which stages does Advent Venture Partners typically target?

Advent Venture Partners focuses primarily on Series A and Series B rounds, occasionally participating in growth-stage financings. The firm has historically led or co-led first institutional rounds in enterprise software and life sciences companies across Europe. It does not operate a seed-stage program as a distinct vehicle.

How does Advent Venture Partners source deal flow?

The firm sources primarily through its four-decade network within European technology hubs, particularly in the UK, Nordics, and DACH region. Its longevity in a market once underserved by venture capital gives it access to founder referrals and repeat-entrepreneur deal flow. Advent does not publicly operate accelerator programs or venture-studio structures.

What is Advent Venture Partners' exit track record?

The firm has realized exits through both IPOs and trade sales. Notable outcomes include the acquisition of QlikTech by Thoma Bravo and the public listing of Sophos on the London Stock Exchange. Its strategy often involves guiding portfolio companies toward acquisition by US-based strategic buyers, a channel built through partner relationships over multiple cycles.

Is Advent Venture Partners related to Advent International?

No. Advent Venture Partners is a distinct, independent firm headquartered in London focused on venture and growth-stage technology and life sciences. Advent International is a separate, Boston-headquartered global private equity firm with a buyout focus. The two firms share historical naming conventions common to the era in which they were founded but have no ownership or operational link.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on venture capital firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More London Venture Capital profiles